Statistics

Total Visits

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel52

Select a period of time:

Number of views in the range

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel10

Views

Views
September 20251
October 20250
November 20251
December 20253
January 20263
February 20260
March 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
Argentina1
Ecuador1
Paraguay1
Singapore1
Turkey1
Uruguay1
 

Top cities views

Views
San Jose2
Antalya1
Cayambe1
Dallas1
Lomas de Zamora1
Montevideo1
San Alberto1